David Hanley
Vermogen: 114 720 $ op 31-05-2026
Vermogen: 114 720 $ op 31-05-2026
David C.
Hanley is Chief Technical Operations Officer at Nuvation Bio, Inc. since 2021.
Formerly, Senior Director-Global Pharmaceutical Development at The Medicines Co. from 2011 to 2014, VP-Pharmaceutical Sciences & Technical Operations at Radius Health, Inc. from 2014 to 2018, and Senior VP & Head-Global Pharmaceutical Development at BioXcel Therapeutics, Inc. from 2018 to 2021.
Education includes a doctorate from the University of Utah and an undergraduate degree from Virginia Commonwealth University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 27-02-2026 | 24.000 ( 0,01% ) | 114 720 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| NUVATION BIO INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2021 |
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Corporate Officer/Principal | 01-05-2021 |
| RADIUS HEALTH, INC. | Corporate Officer/Principal | 01-08-2018 |
| THE MEDICINES COMPANY | Corporate Officer/Principal | 01-08-2014 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
The Medicines Co.
The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
University of Utah
University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Virginia Commonwealth University
Virginia Commonwealth University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioXcel Therapeutics, Inc.
BioXcel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops transformative medicines in neuroscience and immuno-oncology | Health Technology |
Nuvation Bio, Inc.
Nuvation Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops oncology related novel therapeutic candidates | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau